Fucosylated N-glycans as early biomarkers of COVID-19 severity
Beatrix Paton(Centre for Omic Sciences), Manuel Suárez(Institut de Recerca Biomèdica Catalunya Sud), Anna Rull(Institut de Recerca Biomèdica Catalunya Sud), Pol Herrero(Centre for Omic Sciences), Antoni del Pino(Centre for Omic Sciences), Sílvia Chafino(Instituto de Salud Carlos III), Fréderic Gómez-Bertomeu, Javier Martínez‐Picado(Universitat de Vic - Universitat Central de Catalunya), Joaquim Peraire(Instituto de Salud Carlos III), Núria Canela-Canela(Consejo Superior de Investigaciones Científicas)
Cited by 14
Related Papers
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
|The Lancet HIV|2019|206
In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation
|Nature Medicine|2023|156
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
|The Lancet HIV|2021|110
Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection
|EBioMedicine|2019|81
Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure
|Scientific Reports|2020|75